Female Sexual Function Index (FSFI): Complete Guide to Understanding, Scoring, and Interpretation

Alex Bendersky
September 29, 2025

The Female Sexual Function Index stands out as a leading tool to assess women's sexual function. Medical professionals have cited it nearly 10,000 times on Google Scholar by May 2019. Healthcare providers now use this standardized questionnaire as a vital instrument to evaluate sexual health in women from a variety of populations and clinical settings.

The FSFI's reach extends far beyond English-speaking regions. Medical professionals have translated it into 20 other languages, which shows how well it works worldwide. The tool's reliability makes it a trusted choice for healthcare professionals. This is a big deal as it means that Cronbach's alphas are above 0.9 for all subscales, paired with strong test-retest reliability (r = 0.79–0.88). Medical professionals use a cutoff score of 26.55 to separate women with female sexual dysfunction (FSD) from those without it. A score of 5 on the Desire domain helps identify hypoactive sexual desire disorder (HSDD).

This piece delves into what doctors want their patients to know about the Female Sexual Function Index in 2025. You'll learn about its development, scoring system, domains, and how doctors use it in clinical settings.

Key Takeaways

Understanding the FSFI empowers both healthcare providers and patients to address female sexual health with precision and confidence through evidence-based assessment.

• The FSFI uses a cutoff score of 26.55 to identify sexual dysfunction and evaluates six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain over four weeks.

• Proper scoring requires applying specific domain factors (0.6 for desire, 0.3 for arousal/lubrication, 0.4 for others) to avoid inflated results outside the 2-36 range.

• "No sexual activity" responses should be treated as missing data, not dysfunction indicators, to prevent artificially high dysfunction rates in studies.

• The FSFI alone cannot diagnose sexual dysfunction; it must be combined with distress measures since both DSM-5 and ICD-11 require significant distress for diagnosis.

• With translations in 20+ languages and excellent reliability (Cronbach's alpha >0.9), the FSFI remains the global gold standard for assessing female sexual function in clinical and research settings.

The FSFI's strength lies in its comprehensive approach to female sexuality assessment, but its effectiveness depends entirely on proper administration, scoring, and interpretation alongside appropriate distress evaluation tools.

What is the Female Sexual Function Index (FSFI)?

The Female Sexual Function Index (FSFI), created in 2000, serves as a detailed self-report questionnaire that helps assess sexual function in women. This 19-item tool measures six key areas of female sexual functioning: desire, arousal, lubrication, orgasm, satisfaction, and pain.

Why was FSFI developed?

Eight experts in female sexuality saw the need to create a standardized measurement tool. They based it on diagnostic frameworks from DSM-IV and ICD-10. The team developed this instrument after they took a closer look at existing literature.

The original focus centered on Female Sexual Arousal Disorder (FSAD). This happened because pharmaceutical companies wanted to develop treatments for arousal disorders in women after introducing sildenafil in 1998. The creators managed to keep separate domains for desire and arousal disorders. This allowed them to get a full picture of how specific treatments worked, even though these disorders often overlap.

How did it become the gold standard?

FSFI's reputation as the gold standard comes from thorough testing and wide acceptance. The tool showed excellent internal reliability with Cronbach's alpha values above 0.9 for all subscales and good test-retest reliability (r = 0.79-0.88).

The index's ability to distinguish between women with and without sexual dysfunction made it a trusted diagnostic tool. Research showed that 26.55 was the best cut-off score to identify women with sexual dysfunction.

FSFI has now been translated and validated in more than 20 languages, making it available to researchers and clinicians worldwide. With over 1,000 published manuscripts citing the original article, FSFI stands as the de facto gold standard in measuring female sexual function.

Who should use the FSFI?

We validated FSFI for sexually active, heterosexual women. Research supports its use with lesbian women, too. The questionnaire works well in a variety of populations, including:

  • Women with various sexual dysfunction diagnoses
  • Gynecologic, breast, rectal, and urologic cancer patients/survivors
  • Women with medical conditions such as diabetes and pelvic organ prolapse
  • Women at different life stages

Healthcare professionals in sexology, gynecology, and venereology find FSFI valuable. Physicians use it to screen patients for potential sexual disorders and refer at-risk cases to sexual medicine specialists. More than that, researchers often use FSFI in clinical trials to assess how well treatments work for female sexual dysfunction.

How FSFI is Scored and Interpreted?

The FSFI employs a well-laid-out scoring method that turns questionnaire answers into meaningful clinical measurements. Knowing how this system works helps practitioners interpret results correctly in clinical and research environments.

Overview of the FSFI scoring system

The FSFI has 19 self-reported items that measure sexual function during the previous four weeks. Each item uses a 5-point Likert scale with scores from 0 (or 1) to 5. Higher scores show better sexual functioning. The system includes 15 items with a zero-score option that shows "no sexual activity". Questions 1, 2, 15, and 16 receive scores from 1-5, while other items range from 0-5. Original recommendations suggest excluding unanswered questions when calculating scores.

Domain weightings and total score range

The system calculates individual domain scores through specific weights:

Domain Scoring System
Domain Questions Score Range (per item) Weight Formula Domain Score Calculation
Desire Q1–Q2 1–5 × 0.6 (Q1 + Q2) × 0.6
Arousal Q3–Q6 0–5 × 0.3 (Q3 + Q4 + Q5 + Q6) × 0.3
Lubrication Q7–Q10 0–5 × 0.3 (Q7 + Q8 + Q9 + Q10) × 0.3
Orgasm Q11–Q13 0–5 × 0.4 (Q11 + Q12 + Q13) × 0.4
Satisfaction Q14–Q16 0/1–5 × 0.4 (Q14 + Q15 + Q16) × 0.4
Pain Q17–Q19 0–5 × 0.4 (Q17 + Q18 + Q19) × 0.4

Domain factors normalize each domain's contribution to the final score. Each domain adds a maximum of 6 points. Adding all six domain scores gives the total FSFI score, which ranges from 2.0 to 36.0.

Understanding the FSFI cutoff scores

Research shows that a total FSFI score of ≤26.55 works best to distinguish between women with and without sexual dysfunction. This threshold identified 70.7% of women with sexual dysfunction and 88.1% of sexually functional women in cross-validation samples accurately.

Domain-specific cutoffs provide additional insights. A cutoff score of 5 on the Desire domain helps identify women with hypoactive sexual desire disorder. This is a big deal as it means that the FSFI's internal reliability has Cronbach's alpha values above 0.9 for the full scale and exceeds 0.8 for all subscales. These numbers prove it's a reliable tool to assess female sexual function.

Breaking Down the FSFI Domains

The Female Sexual Function Index domains each look at different parts of female sexuality and give detailed insights into sexual health.

Desire

Sexual motivation shows up in the Desire domain by looking at how often and how strong sexual desires are. Two items rated on a 5-point scale make up this domain, with scores from 1.2 to 6. This domain stands out because it works independently, and its cutoff score of 5 helps identify hypoactive sexual desire disorder.

Arousal

A woman's sexual arousal levels during activity are measured through four items on a 6-point scale (0-5). The final score ranges from 0-6 after multiplying by 0.3.

Lubrication

This domain reviews proper lubrication during sexual activity with four items. Scores range from 0-5 with a 0.3 weight factor, and the domain associates strongly with the Pain domain.

Orgasm

The Orgasm domain uses three items with a 0.4 weight to measure knowing how to reach climax and its quality. Sexual satisfaction substantially depends on this essential component.

Satisfaction

Three questions scored from 0/1-5 with a 0.4 weight measure overall sexual fulfillment. The scores reflect relationship quality and personal sexual well-being.

Pain

Three items in the Pain domain measure discomfort during sexual activity. Research shows it is strongly associated with the total FSFI score and other domains. We focused mostly on Lubrication, which shows how these sexual function domains connect.

Common Mistakes and Best Practices in FSFI Use

Researchers make several common mistakes that affect the validity despite the FSFI's widespread use. Getting a full picture of female sexual function requires understanding these pitfalls.

Scoring errors to avoid

Many studies don't multiply domain sums by their domain factors (0.6 for desire; 0.3 for arousal and lubrication; 0.4 for orgasm, satisfaction, and pain). This mistake gets more and thus encourages more artificially inflated scores beyond the possible range of 2-36. Studies also incorrectly use reference periods that differ from the required four-week timeframe.

Using FSFI with sexually inactive women

The biggest problem affects all but one of these items that include a "no sexual activity" zero-score option. Scores become artificially lower when these zeros indicate dysfunction instead of sexual inactivity. Studies should exclude sexually inactive participants or treat zero responses as missing values. Dysfunction rates can appear inflated—reaching 60% instead of 52% when calculated correctly.

Why does distress measurement matter?

FSFI cannot diagnose sexual dysfunction alone because it doesn't measure distress. DSM-5 and ICD-11's most important requirement is significant distress. A more complete clinical assessment comes from combining FSFI with distress measures like the Female Sexual Distress Scale (FSDS).

How to use FSFI in clinical trials?

Clinical trials need clear exclusion criteria for zero responses. Current versions might not fully represent patient experiences in a variety of situations.

Conclusion

The Female Sexual Function Index has become a great way to get insights for healthcare professionals who assess women's sexual health in 2025. This 19-item questionnaire, 25 years old now, has shown remarkable reliability and works well in a variety of populations. Healthcare providers find special value in the cutoff score of 26.55 that identifies sexual dysfunction and the threshold of 5 on the Desire domain that diagnoses hypoactive sexual desire disorder.

The six distinct domains, desire, arousal, lubrication, orgasm, satisfaction, and pain, give doctors a complete picture of specific areas of sexual function. This layered approach helps create targeted treatments based on what each patient needs, rather than using one-size-fits-all plans.

In spite of that, getting accurate results needs careful attention to scoring protocols. Many researchers make mistakes by not applying domain factors or misreading "no sexual activity" responses. These errors can throw off results by a lot and lead to higher dysfunction rates than actual. Healthcare professionals must stick to standard procedures when they give and interpret the FSFI.

The FSFI works well as a screening tool, but it doesn't measure distress, a key factor needed to diagnose sexual dysfunction according to DSM-5 and ICD-11 criteria. Using the FSFI together with distress assessment tools like the Female Sexual Distress Scale creates a better clinical evaluation.

The FSFI remains the gold standard in female sexual function assessment because of its strong measurement properties and worldwide use. As medical knowledge of female sexuality keeps growing, this verified tool will without doubt keep its central role in both clinical practice and research. This helps healthcare providers deliver more tailored and effective care for women with sexual health concerns.

FAQs

Q1. What is considered a normal FSFI score?

FSFI scores range from 2 to 36, with higher scores indicating better sexual function. A score above 26.55 is generally considered normal, while scores below this threshold may indicate sexual dysfunction. However, interpretation should always be done in conjunction with clinical assessment.

Q2. How is the Female Sexual Function Index (FSFI) structured?

The FSFI is a 19-item questionnaire that assesses six domains of female sexual function: desire, arousal, lubrication, orgasm, satisfaction, and pain. It evaluates sexual function over the previous four weeks and uses a scoring system that weights each domain to contribute to the total score.

Q3. Which healthcare professional should I consult for female sexual problems?

For female sexual health concerns, it's best to start with a gynecologist. They are trained to address various aspects of sexual health, including preventive care and diagnosis of issues related to female reproductive organs. If needed, they may refer you to a specialist in sexual medicine for more specific treatment.

Q4. How does age impact FSFI scores?

Research suggests that FSFI scores tend to decrease with age, with an average decline of 0.41 points for each year of age. This indicates that older women may be at higher risk of experiencing sexual function issues. However, individual experiences can vary greatly.

Q5. Can the FSFI alone diagnose sexual dysfunction?

No, the FSFI alone cannot diagnose sexual dysfunction. While it's an excellent screening tool, a diagnosis of sexual dysfunction requires the presence of significant distress, which the FSFI doesn't measure. Healthcare providers often combine the FSFI with other assessments, such as the Female Sexual Distress Scale, for a more comprehensive evaluation.

Share on Socials:

Reduce costs and improve your reimbursement rate with a modern, all-in-one clinic management software.

Get a Demo
Table of Content

Webinar

From Claims Delays to Clean Approvals: How AI Helps Clinics Win

September 17, 2025
1 p.m. - 2 p.m. EST
Register Now